Molecular Cloning of Ly-1, a Membrane Glycoprotein of Mouse T Lymphocytes and a Subset of B Cells: Molecular Homology to Its Human Counterpart Leu-1/T1 (CD5)
Overview
Affiliations
We report the isolation of cDNA clones of the mouse lymphocyte differentiation antigen Ly-1. One of these cDNA clones was confirmed to be full-length by DNA sequencing and by expression of Ly-1 by L cells transfected with this clone. Analysis of the predicted amino acid sequence indicated that the Ly-1 polypeptide is synthesized with a 23 amino acid leader and that the mature protein consists of an amino-terminal region of 347 amino acids, a transmembrane sequence of 30 residues, and a carboxyl-terminal region of 94 amino acids. The amino-terminal region appears to be divided into two subregions by a threonine- and proline-rich sequence of 23 amino acids that is highly conserved between Ly-1 and its human homologue Leu-1 (CD5) in position and amino acid composition. The first amino-terminal subregion of 111 amino acids is predicted to be arranged in a beta-pleated sheet structure of six strands. The entire amino-terminal region is rich in cysteine, with all of its 22 cysteine residues conserved between Ly-1 and Leu-1. The carboxyl-terminal region has no cysteines. Ly-1 and Leu-1 are 63% identical, with a gradient of identical residues from 43% for the first amino-terminal subregion to 58% for the second amino-terminal subregion and 90% for the carboxyl-terminal region. The predicted secondary structure of the first amino-terminal subregion and identities of certain conserved residues among most members of the immunoglobulin gene superfamily suggest that Ly-1 and Leu-1 are distant members of this family.
Adegoke A, Thangavelu G, Chou T, Petersen M, Kakugawa K, May J Open Biol. 2024; 14(10):240178.
PMID: 39471840 PMC: 11521602. DOI: 10.1098/rsob.240178.
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.
Zu Y, Ren Q, Zhang J, Su H, Lu Q, Song Y Exp Hematol Oncol. 2024; 13(1):104.
PMID: 39462383 PMC: 11515150. DOI: 10.1186/s40164-024-00577-5.
Gangani D, Dissanayake W, de Silva R, Anuradha K, Karunanayake L, Fernando N BMC Immunol. 2023; 24(1):39.
PMID: 37848809 PMC: 10583450. DOI: 10.1186/s12865-023-00574-z.
Caracciolo D, Mancuso A, Polera N, Froio C, DAquino G, Riillo C Exp Hematol Oncol. 2023; 12(1):5.
PMID: 36624522 PMC: 9828428. DOI: 10.1186/s40164-022-00368-w.
CD5 Controls Gut Immunity by Shaping the Cytokine Profile of Intestinal T Cells.
Schuster C, Kiaf B, Hatzihristidis T, Ruckdeschel A, Nieves-Bonilla J, Ishikawa Y Front Immunol. 2022; 13:906499.
PMID: 35720357 PMC: 9201032. DOI: 10.3389/fimmu.2022.906499.